SG Americas Securities’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-39,200
Closed -$8K 3367
2022
Q3
$8K Buy
+39,200
New +$1.38M ﹤0.01% 3129
2020
Q2
Sell
-34,900
Closed -$92K 3853
2020
Q1
$92K Buy
+34,900
New +$4.06M ﹤0.01% 3036

Other funds holding TDOC

SG Americas Securities's TDOC Position: Q1 2026 in Review

SG Americas Securities reduced its Teladoc Health (TDOC) stake by 2.7% in Q1 2026, selling an estimated $198K and leaving 1,261,856 shares worth $6.88M. The position accounts for 0.01% of the portfolio, ranked #927.

SG Americas Securities first reported a position in TDOC in Q4 2017 and has held it in 32 quarters since. The position peaked at $23.4M in Q4 2019. 323 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • SG Americas Securities held 1,261,856 shares of Teladoc Health worth $6.88M as of Q1 2026.
  • SG Americas Securities sold 35,329 Teladoc Health shares in Q1 2026, an estimated $198K.
  • Teladoc Health made up 0.01% of SG Americas Securities's portfolio in Q1 2026, its #927 holding.
  • SG Americas Securities first reported a position in Teladoc Health in Q4 2017 and has held it in 32 quarters since.
  • SG Americas Securities's Teladoc Health position peaked at $23.4M in Q4 2019.
  • 323 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.